Gilad Gordon, MD, MBA, President, ORRA Group, LLC and Associate Clinical Professor of Medicine, University of Colorado School of Medicine and Joia Mukherjee, MD, MPH, Associate Professor of Medicine, Harvard Medical School; Chief Medical Officer, Partners in Health (PIH)
Overview
The COVID-19 conversation is turning towards how we can best re-open society. Two of the pillars of our future new normal are a vaccine, and an effective testing/contact tracing program. In this webinar, panelists discuss the latest updates on vaccine clinical trials (including Moderna’s phase I report) and the ambitious contact tracing partnership between Partners in Health and the state of Massachusetts. Besides intrinsic technical or logistical challenges, both of these potential solutions also raise tough questions about how effectively and fairly they can be rolled out given our frayed system of health care delivery. Listen as these experts explore technologic progress but also take a holistic view of how new solutions might work within the reality of our public health infrastructure.
This is part four in a four part series with Harvard Medical School Executive Education and STAT News